Cargando…
Potential Biomarkers to Distinguish Type 1 Myocardial Infarction in Troponin-Elevated Diseases
Classifying myocardial infarction by subtype is crucial for appropriate patient management. Although troponin is currently the most commonly used biomarker, it is not a specific marker for myocardial infarction and cannot distinguish subtypes. Furthermore, previous studies have confirmed that protei...
Autores principales: | Kwon, Sohyen, Park, Sang-Hyun, Mun, Sora, Lee, Jiyeong, Kang, Hee-Gyoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179038/ https://www.ncbi.nlm.nih.gov/pubmed/37175804 http://dx.doi.org/10.3390/ijms24098097 |
Ejemplares similares
-
Biomarker Discovery of Acute Coronary Syndrome Using Proteomic Approach
por: Shin, Miji, et al.
Publicado: (2021) -
Serum biomarker discovery related to pathogenesis in acute coronary syndrome by proteomic approach
por: Shin, Miji, et al.
Publicado: (2021) -
Serum biomarker panel for the diagnosis of rheumatoid arthritis
por: Mun, Sora, et al.
Publicado: (2021) -
Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach
por: Choi, Hyebin, et al.
Publicado: (2021) -
Kinetics of cardiac troponin and other biomarkers in patients with ST elevation myocardial infarction
por: Henrik Kristensen, Jonas, et al.
Publicado: (2023)